Arq92inhibitor.com - Validation with the Alzheimer Illness Dementia Conversion-Related Design as a possible ATN Biomarker of ARQ092 Inhibitor
Hier klicken
um zu Voten!
ARQ 092 HCl is really a novel, orally bioavailable and selective AKT path inhibitor
- Platzierung
- Noch nicht platziert
- Votes
- Noch keine erhalten
- Beliebt seit
- 04.03.2024
Informationen zur Webseite
| Domain | arq92inhibitor.com |
|---|---|
| Homepage URL | https://arq92inhibitor.com/validation-with-the-alzheimer-illness-dementia-conversion-related-design-as-a-possible-atn-biomarker-of/ |
| Keywords | arq 092 inhibitor lpa receptor agonist population bioequivalence |
| Sprache | englisch |